Goldman Sachs expects Nvidia ’beat and raise,’ lifts price target to $240
Retractable Technologies Inc (NASDAQ:RVP), a medical device company with a market capitalization of $29 million, saw its President and CEO Shaw Thomas J. report purchasing 10,000 shares of common stock on October 22, 2025, at a price of $0.96 per share, for a total transaction value of $9600. The purchase comes as InvestingPro analysis shows the company maintains a strong balance sheet with more cash than debt, despite recent cash burn concerns.
Following the transaction, Shaw directly owns 15,733,029 shares of Retractable Technologies Inc . Shaw also indirectly owns 831,600 shares over which he has voting or investment control. The stock, which has gained over 23% in the past six months, currently trades at $0.99 and appears undervalued according to InvestingPro’s Fair Value analysis.
In other recent news, Retractable Technologies, Inc. has announced a workforce reduction of approximately 12.4%, impacting mainly manufacturing and support roles. The company anticipates saving about $1.6 million annually in wages and benefits, which accounts for roughly 8.6% of its total workforce costs. However, these savings will be slightly offset by one-time separation payments totaling approximately $56,000 for the affected employees. This decision comes amid ongoing tariff pressures that have been affecting the company. The reduction is part of Retractable Technologies’ strategy to manage costs more effectively in the current economic climate. While the company did not provide further details on the tariff issues, the move indicates a strategic adjustment to maintain financial stability. Investors may want to monitor how these changes impact the company’s operational efficiency and overall financial health in the coming quarters.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.